Sd. Friedman et al., LONG-TERM MONOAMINE DEPLETION, DIFFERENTIAL RECOVERY, AND SUBTLE BEHAVIORAL IMPAIRMENT FOLLOWING METHAMPHETAMINE-INDUCE NEUROTOXICITY, Pharmacology, biochemistry and behavior, 61(1), 1998, pp. 35-44
Squads of rats were assayed at three intervals following MA-induced ne
urotoxicity to investigate the persistence of monoamine deficits, the
potential for monoamine recovery, and spatial task abilities. At 48, 1
39, and 237 days postinjection, MA animals showed significant monoamin
e depletions compared with controls. Investigating percent depletions
(MA/control) across time showed monoamine recovery in some structures.
Initially, 5-HT within medial prefrontal cortex (MPFC), caudate (CdN)
, and hippocampus (HPC) was reduced to 30% of control levels. By 237 d
ays, MPFC and CdN levels were elevated to 70%. Similarly, initial CdN
BA reductions (30% nf control levels) showed recovery to 80% by 237 da
ys. These findings support neurochemical recovery following MA neuroto
xicity. However, the persistent depression of HPC 5-HT suggests that n
ot all structures recover equally. The HPC did show elevated turnover
(metabolite/neurotransmitter) over time: suggesting a unique compensat
ory response. MA treatment also produced an impairment in the Morris w
ater-maze place task at 65 days postinjection. No impairments were obs
erved in water-maze moving platform or place task at 79 and 165 days p
ostinjection, respectively, or in T-maze alternation. The possibility
that partial recovery in tissue monamine levels underlies the sparing
of function and behavioral improvement is discussed. (C) 1998 Elsevier
Science Inc.